Supporting pharmaceutical, biosimilar, medical device, cosmetic and food supplement companies with regulatory affairs, drug registration in Egypt, CTD dossier preparation, eCTD publishing and submission services across Egypt, GCC, Jordan and the MENA region.
Comprehensive regulatory support across the product lifecycle.
Byet El Khebra delivers strategic regulatory affairs, drug registration, CTD/eCTD submissions, quality compliance and regulatory consulting services for pharmaceutical, biosimilar, medical device, cosmetic and food supplement companies across Egypt and the MENA region.
500+ Registered Products — Proven regulatory success across pharmaceuticals, biosimilars, medical devices, cosmetics, food supplements and healthcare products.
Supporting regulatory success across diverse healthcare sectors through specialized regulatory affairs, registration, compliance and submission services for pharmaceutical companies, biosimilar developers, medical…
Supporting regulatory success across diverse healthcare sectors through specialized regulatory affairs, registration, compliance and submission services for pharmaceutical companies, biosimilar developers, medical device companies, IVD manufacturers, cosmetic companies, food supplement companies, pharmacovigilance offices and healthcare startups.
• Pharmaceutical Companies • Biosimilar Developers • Medical Device Companies • IVD Manufacturers • Cosmetic Companies • Food Supplement Companies • Pharmacovigilance Offices • Healthcare Startups
Answers to common questions about drug registration in Egypt, CTD/eCTD submissions, regulatory affairs, pharmacovigilance, medical device registration and quality compliance services.
Still Have Questions?
Consult a Specialist20+ Years of Regulatory Expertise — Extensive experience in registration strategy, regulatory planning, submission management and product lifecycle support.
CTD & eCTD Center of Excellence — Specialized expertise in CTD dossier preparation, eCTD publishing, lifecycle management and regulatory documentation.
Strategic Regulatory Excellence — Combining regulatory strategy, scientific assessment and practical execution to support successful registrations and sustainable business growth.
A Strategic Model for Regulatory Excellence, Compliance, and Market Access in Pharmaceutical and Healthcare Markets
"Regulatory affairs is not paperwork — it is strategy."
"Regulatory affairs is not paperwork — it is strategy."
The Regulatory Science Framework™ is a strategic model developed by Dr. Asmaa Hussien to support regulatory excellence, scientific decision-making, compliance management, and market access across pharmaceutical, biotechnology, biosimilar, medical device, and healthcare sectors. Developed through more than 20 years of regulatory practice and supported by experience across more than 500 healthcare product registrations, the framework provides healthcare organizations with a structured methodology for navigating complex regulatory environments while maintaining compliance, quality, and patient-centered outcomes. The framework integrates regulatory science, regulatory strategy, drug registration, CTD and eCTD submissions, pharmacovigilance, quality systems, risk management, and lifecycle planning into a unified approach that strengthens regulatory performance and accelerates healthcare innovation. The book is available free of charge for healthcare professionals, regulatory affairs specialists, quality leaders, compliance professionals, pharmaceutical companies, biotechnology organizations, medical device manufacturers, researchers, students, and healthcare decision-makers — available for free online reading and PDF download through the official Byet El Khebra website.
Tell us about your product, regulatory challenge or project objectives and our experts will help you identify the most appropriate regulatory pathway.